Internet healthcare solutions provider Fangzhou has entered a partnership with Tencent Health and Tencent Cloud, aiming to expedite AI-driven healthcare solutions with the integration of the DeepSeek open-source AI model into its platform.
This move is expected to bolster the capabilities of Fangzhou’s AI Agent 2.0 platform to enhance pharmaceutical logistics along with online healthcare services.
Go deeper with GlobalData
Fangzhou’s recent deployment of the DeepSeek open-source large language model in February has set the stage for this partnership, which utilises Tencent Cloud’s infrastructure to power the AI Agent 2.0 platform.
The platform is now equipped with DeepSeek’s analytical prowess and Tencent’s Hunyuan model, focusing on improving the efficiency of the healthcare sector.
DeepSeek’s model is chosen for its performance, cost-effectiveness, and security features.
Its scalable efficiency is attributed to the mixture-of-experts (MoE) architecture, and its private deployment model aligns with stringent data privacy regulations by avoiding the transmission of customer data to third parties.
Fangzhou’s AI platform is adept at rapid local deployment of various large language models, which facilitated the swift integration of DeepSeek’s technology.
The support from Tencent Cloud’s infrastructure has enabled Fangzhou to improve its platform’s capabilities, offering improved services to patients and healthcare providers.
The AI Agent 2.0 deployment marks a significant development in the strategic partnership between Fangzhou, Tencent Health and Tencent Cloud.
This upgraded system is now better positioned to address patient services, physician workflows, and the development of new functionalities and data-driven improvements.
In December last year, Fangzhou announced a collaboration with Bristol Myers Squibb.
This partnership focused on fostering innovation in internet healthcare, particularly in the development of digital platforms and models for internet-based chronic disease care.
